Claris Injectables Limited, a wholly-owned subsidiary of Claris Lifesciences Limited - collectively ‘Claris’, is a sterile injectables pharmaceutical company with its market presence across the world. Claris manufactures and/or markets products across multiple delivery systems, markets, and therapeutic segments, including anesthesia & analgesics, blood products, anti-infectives, critical care, and nephrology. A significant majority of these products are generic drugs, capable of being directly injected into the human body, predominantly used in the treatment of critical illnesses. Our customer base primarily includes government and semi-government institutions, group corporate hospitals, standalone prominent hospitals, and nursing homes.With emphasis on quality, technology, and innovation, we offer a range of niche technol Click for details>>